{
  "trial_id": "NCT01372618",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "21 years of age and older",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Must sign informed consent, witnessed, and dated prior to entry",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "The participant has breast biopsy consistent with Ductal Carcinoma in situ (DCIS)",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Performance Status: ECOG 0-1 unless mobility is limited from chronic physical handicap",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "No clinical evidence of other malignancies (except Basal Cell carcinoma)",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Complete blood count, differential and platelet count must be WNL or verified by the study chair to be related to conditions not interfering with normal health status",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Adequate hepatic and renal function (these must be WNL or verified by study chair to be related to conditions not interfering with normal health status)",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Normal fasting glucose",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "No history of diabetes",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Medically and Psychologically able to comply with all study requirements",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Accessible for Follow up",
      "label": "met",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Less than 21 years of age",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Known invasive breast cancer of any type",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Bilateral prophylactic mastectomy",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Prior malignancy of any type that occurred less than 5 years previously, except for basal or squamous cell carcinoma of the skin or carcinoma in situ of the cervix",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Existing non-malignant disease that would preclude the administration of pasireotide",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Pregnancy: All subjects will have a beta-hCG serum pregnancy test to rule out pregnancy, a history will also be taken to make certain that recent sexual exposure does not put them at risk for pregnancy. If so a second serum pregnancy test will be done. Volunteers will be asked to use barrier contraception during study.",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Tamoxifen or other preventive measures within 6 months",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Serious Psychiatric condition or addictive disorder",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Diabetes or elevated fasting blood sugar either by history or by HgbA1c greater than 6.5% or fasting serum glucose greater than 100mg/dL on screening labs. If fasting serum glucose is greater than 100mg/dL on screening labs, this test will be repeated to confirm the results",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Inability to inject medication or test for finger stick glucose",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Gall bladder disease",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "25",
    "trial_id": "NCT01372618",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}